Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Category : Search result: pharmaceutical chemicals
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
AgentForce AI Revolutionizes Life Sciences Engagement in India
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Baddi Pharma Raid: Sub-Standard Medicines Shipped to Rajasthan
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
US Tariffs Impact Indian Exports Across Key Sectors
Recent trade data reveals how US tariffs are affecting Indian exports across critical sectors including chemicals, apparel, and machinery. Get insights into the shifting trade dynamics.
Fineotex Chemical Soars 20%, Up 44% in 2 Sessions
Fineotex Chemical shares continue their spectacular rally with another 20% upper circuit. Discover why this Ashish Kacholia-backed specialty chemical stock has surged 44% in just two trading sessions and what's driving investor frenzy.
Roasted Chickpeas Health Risks: Expert Warning
Popular roasted chickpeas may contain harmful chemicals and excess sodium. Expert dietitian explains health risks and shares safer preparation methods for this protein-rich snack.
Indian Exports to US Crash 37.5% Amid Trump Tariffs
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
US Tariffs Crush Indian Exports: 37.5% Plunge
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
Q2 Results 2025: Urban Company, Tata Chemicals Among 27 Earnings
Stock market investors brace for major Q2 earnings announcements as Urban Company, Tata Chemicals and 25 other companies set to reveal financial performance today. Get complete list and analysis.
FDA Recalls Blood Pressure Meds Over Cancer Risk
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Navin Fluorine Soars 17% to Record High on Bullish Calls
Navin Fluorine International shares skyrocket over 17% to all-time high as analysts raise target prices following strong Q2 performance. Discover why the specialty chemicals stock is buzzing.
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Sharda Cropchem Q2 Profit Jumps 75%, Revenue Up 20%
Agrochemical major Sharda Cropchem delivers stellar Q2 performance with massive profit growth and strong revenue increase, showcasing robust demand in global markets.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Texas Sues Johnson & Johnson Over Tylenol-Autism Link
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Sanofi India appoints Deepak Arora as Managing Director
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India probes anti-dumping of TB drugs from China, Thailand
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
LTIMindtree wins $100M US chemicals deal
Indian IT major LTIMindtree lands transformative multi-year contract with leading US-based chemicals and polymers manufacturer, expanding global footprint.
Stock Split & Bonus Issue Approved for Small-Cap Chemical Firm
A specialty chemicals small-cap company receives shareholder approval for corporate actions including stock split and bonus issue, potentially creating new opportunities for investors.
Page 3 of 4